COVID vaccine efficacy against Delta variant up to 92% for 50-75-year-olds: French Study |
Clinical News
eMediNexus Coverage from: 
COVID vaccine efficacy against Delta variant up to 92% for 50-75-year-olds: French Study

1 Read Comments                

Vaccination has been found to be highly effective at preventing severe COVID-19, even against the Delta variant, stated a study conducted in France.The study, aimed at prevention of severe COVID-19 and death, assessed 22 million individuals aged above 50 years. Researchers noted that those who had received vaccination were 90% less likely to be hospitalized or die due to COVID. The study involved vaccination with Pfizer/BioNtech, Moderna and AstraZeneca shots. Vaccination against COVID-19 w...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now